Novartis Challenges $1.3M Verdict In Zometa Jaw Injury Suit

Law360, New York (September 23, 2013, 8:21 PM EDT) -- Novartis Pharmaceutical Corp. moved for a new trial Friday immediately after a Florida jury awarded $1.3 million in damages to a Zometa user who allegedly suffered jaw death, pointing to a perceived inconsistency in an original verdict scrapped by the court.

Friday's verdict against Novartis on negligent and strict liability failure-to-warn claims came after U.S. District Judge Gregory Presnell rejected the jury's verdict reached earlier that day because its finding against Novartis on the negligent failure-to-warn claim contradicted its finding for the company on the strict...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Guenther et al v. Novartis Pharmaceutical Corporation


Case Number

6:08-cv-00456

Court

Florida Middle

Nature of Suit

Personal Inj. Prod. Liability

Judge

Gregory A. Presnell

Date Filed

March 28, 2008

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.